glp-1 agonist dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and in Diabetes Mellitus GLP-1 RA in Diabetes-Related Neurodegenerative

Hence, anticancer therapy may include antidiabetic drugs targeting glucose metabolism and metabolic pathways that decrease the glucose uptake in cancer cells [30]

In a Phase II readout released in August 2022, the pharma touted a 15.6% drop in body weight in patients taking CagriSema, versus 5.1% in comparators on semaglutide alone and 8.1% in patients treated with only cagrilintide

It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]

Start moving in the direction of a healthier and happier version of yourself

The researchers reported HRs of: 0.83 (95% CI, 0.7-0.97) for suicide death and nonfatal self-harm

The scale refused to budge